Optimizing Phase III Trials in Pancreatic Cancer - ESMO Poster 2024
Using the Aurora Suite we compared the phase III trial 'POLO' with our results. The Aurora Suite could have enabled POLO to enroll more than 200% higher, whilst reducing sites required and enrollment time by ~30%.
Aurora Analytica Presents at ESMO, Barcelona, 2024
We present our poster, "Revolutionizing Clinical Trials: Harnessing Artificial Intelligence for Optimized Phase III Studies in Pancreatic Cancer.